Country: Saudi Arabia

Mammostem

The MammoStem biotechnology company is specialized in the production of autologous mammary stem cells using mammary luminal cells. The generated multipotent stem cells are expected to be utilized in breast reconstruction post-mastectomy and cosmetic purposes.

Read More

King Khaled Eye Specialist Hospital & Research Center

King Khaled Eye Specialist Hospital and research Center (KKESH) is a nonprofit Organization and leading tertiary provider in Eye specialized healthcare in the Kingdome of Saudi Arabia.

Read More

King Fahd University of Petroleum and Minerals

Welcome you to the College of Petroleum Engineering & Geosciences (CPG), King Fahd University of Petroleum and Minerals, Saudi Arabia. A distinguished college of academic excellence and innovation. At CPG, we are dedicated to advancing the fields of petroleum engineering, geosciences, and mining science & engineering through rigorous education, cutting-edge research, and impactful collaborations. Our programs are meticulously crafted to equip students with the knowledge, skills, and experience necessary to lead and excel in these critical and dynamic sectors.

Read More

KaRama Bio

We at KaRama LTD, based in Saudi Arabia and Canada, are a Medical Technology (MedTech) and Biotechnology (BioTech) company focused on transforming the sector through advanced technologies in AI, ML, IoT, CV, Digital Twins, and Biotech Innovation. The Vision is to lead MedTech & BioTech in MENA & North America Regions by promoting R&D and facilitating the adoption of innovative BioTech & MedTech. This vision emphasizes a culture of innovation through partnerships and hubs. ​ Our mission is to develop scalable Health Technology and Biotechnology solutions that drive transformative results for healthcare enterprises. We create customizable platforms for Screening, Diagnosis, and intervention, promoting Life Sciences and AI-driven innovations. | KaRama Bio’s strategic direction is defined by a focus on precision, prevention, and scale. The organization’s vision is for children to outgrow food allergies safely. Critical enablers include advancements in 3D oral immunotherapy, exposomics, artificial intelligence, and digital health. Bold moves such as redefining allergy care, developing national datasets, and adopting a platform model underpin its approach. The main challenges—regulation, adoption, and trust—are addressed through evidence-based solutions.

Read More